Attagene Inc. is a contract research organization that offers unique screening services for the evaluation of biological activities and prediction of potential toxicities of pharmaceuticals, agricultural and industrial chemicals, cosmetics, and nanomaterials. Our services include toxicity pathway profiling (such as oxidative stress, hypoxia, DNA damage, mitochondrial damage, PXR, AhR, microtubule disruption, etc.), human nuclear receptor profiling (complete human nuclear receptor superfamily; estrogen receptors (ER-alpha, ER-beta), androgen receptor (AR), thyroid hormone receptors, PPAR, RAR, LXR, etc.) and GPCR profiling.